Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASML Holding N.V. Interim / Quarterly Report 2009

Jul 15, 2009

3813_iss_2009-07-15_1a2f2d83-4314-4af2-afc7-e5d27eff8c64.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Three months ended, Six months ended,
Jun 29, 2008 Jun 28, 2009 Jun 29, 2008 Jun 28, 2009
(in thousands EUR, except per share data)
Net system sales 725,586 183,259 1,545,572 284,359
Net service and field option sales 118,571 93,341 217,793 175,866
Total net sales 844,157 276,600 1,763,365 460,225
Cost of sales 506,689 242,162 1,052,271 413,425
Gross profit on sales 337,468 34,438 711,094 46,800
Research and development costs, net of credits 130,241 117,890 258,500 236,205
Selling, general and administrative costs 56,368 40,978 113,695 81,973
Income (loss) from operations 150,859 (124,430) 338,899 (271,378)
Interest income (expense) 6,372 (238) 10,573 (1,269)
Income (loss) from operations before income taxes 157,231 (124,668) 349,472 (272,647)
(Provision for) benefit from income taxes 34,746 20,715 (12,372) 51,503
Net income (loss) 191,977 (103,953) 337,100 (221,144)
Basic net income (loss) per ordinary share 0.45 (0.24) 0.78 (0.51)
Diluted net income (loss) per ordinary share 2 0.44 (0.24) 0.78 (0.51)
Number of ordinary shares used in computing per share amounts (in thousands):
Basic 431,221 432,454 431,412 432,283
Diluted 2 434,585 432,454 434,819 432,283

ASML - Summary U.S. GAAP Consolidated Statements of Operations 1

ASML - Ratios and Other Data 1

Three months ended, Six months ended,
Jun 29, 2008 Jun 28, 2009 Jun 29, 2008 Jun 28, 2009
Gross profit as a % of net sales 40.0 12.5 40.3 10.2
Income (loss) from operations as a % of net sales 17.9 (45.0) 19.2 (59.0)
Net income (loss) as a % of net sales 22.7 (37.6) 19.1 (48.1)
Shareholders' equity as a % of total assets 49.7 47.7 49.7 47.7
Income taxes as a % of income before income taxes 22.1 (16.6) (3.5) (18.9)
Sales of systems (in units) 39 10 89 21
ASP of systems sales (EUR million) 18.6 18.3 17.4 13.5
Value of backlog systems (EUR million) 1,106 1,064 1,106 1,064
Backlog systems (in units) 59 43 59 43
ASP of backlog systems (EUR million) 18.8 24.7 18.8 24.7
Value of booked systems (EUR million) 632 394 944 601
Net bookings (in units) 33 15 59 23
ASP of booked systems (EUR million) 19.2 26.3 16.0 26.1
Number of payroll employees in FTEs 6,821 6,597 6,821 6,597
Number of temporary employees in FTEs 1,649 868 1,649 868
Dec 31, 2008 Jun 28, 2009
(in thousands EUR)
ASSETS
Cash and cash equivalents 1,109,184 1,092,660
Accounts receivable, net 463,273 213,532
Finance receivables, net 6,225 52
Current tax assets 87,560 -
Inventories, net 999,150 926,080
Deferred tax assets 71,780 70,486
Other assets 236,077 220,258
Total current assets 2,973,249 2,523,068
Finance receivables, net 31,030 20,609
Deferred tax assets 148,133 198,867
Other assets 88,197 53,764
Goodwill 131,453 134,536
Other intangible assets, net 26,692 22,300
Property, plant and equipment, net 540,640 591,917
Total non-current assets 966,145 1,021,993
Total assets 3,939,394 3,545,061
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 1,008,343 940,918
Long-term debt 647,050 651,917
Deferred and other tax liabilities 209,699 200,578
Provisions 15,495 14,790
Accrued liabilities and other liabilities 70,038 45,618
Total non-current liabilities 942,282 912,903
Total liabilities 1,950,625 1,853,821
Shareholders' equity 1,988,769 1,691,240
Total liabilities and shareholders' equity 3,939,394 3,545,061

ASML - Summary U.S. GAAP Consolidated Balance Sheets 1

Three months ended,
Six months ended,
Jun 29, 2008 Jun 28, 2009 Jun 29, 2008 Jun 28, 2009
(in thousands EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) 191,977 (103,953) 337,100 (221,144)
Depreciation and amortization 26,452 31,660 55,477 69,536
Impairment 93 4,387 1,644 6,979
Loss on disposals of property, plant and equipment 1,311 8,699 2,414 11,338
Share-based payments 3,109 2,581 6,676 6,093
Allowance for doubtful debts (647) 1,177 (107) 1,164
Allowance for obsolete inventory 11,790 43,897 32,556 66,032
Deferred income taxes (54,457) (31,211) (33,868) (58,234)
Change in assets and liabilities (49,651) 113,798 (4,563) 271,512
Net cash provided by operating activities 129,977 71,035 397,329 153,276
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (65,441) (43,336) (120,473) (87,240)
Proceeds from sale of property, plant and equipment - - - 1,200
Net cash used in investing activities (65,441) (43,336) (120,473) (86,040)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (107,447) (86,486) (107,447) (86,486)
Purchase of shares in conjunction with
share-based payment plans - - (87,605) -
Net proceeds from issuance of shares and stock options 552 429 3,527 532
Excess tax benefits from stock options 5,969 469 5,973 248
Net proceeds from other long-term debt - 32 - 32
Redemption and/or repayment of debt - (9) - (9)
Net cash used in financing activities (100,926) (85,565) (185,552) (85,683)
Net cash flows (36,390) (57,866) 91,304 (18,447)
Effect of changes in exchange rates on cash 144 (484) (2,042) 1,923
Net increase (decrease) in cash & cash equivalents (36,246) (58,350) 89,262 (16,524)

ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1

ASML - Quarterly Summary U.S. GAAP Consolidated Statements of Operations 1

Jun 29,
2008
Sep 28,
2008
Dec 31,
2008
Mar 29,
2009
Jun 28,
2009
(in millions EUR, except per share data)
Net system sales 725.6 590.7 380.5 101.1 183.3
Net service and field option sales 118.6 105.8 113.3 82.5 93.3
Total net sales 844.2 696.5 493.8 183.6 276.6
Cost of sales 506.7 431.1 454.8 171.2 242.2
Gross profit on sales 337.5 265.4 39.0 12.4 34.4
Research and development costs, net of credits 130.2 130.2 127.5 118.3 117.9
Selling, general and administrative costs 56.4 51.9 46.7 41.0 41.0
Income (loss) from operations 150.9 83.3 (135.2) (146.9) (124.5)
Interest income (expense) 6.4 7.1 5.0 (1.1) (0.2)
Income (loss) from operations before income taxes 157.3 90.4 (130.2) (148.0) (124.7)
(Provision for) benefit from income taxes 34.7 (17.1) 42.2 30.8 20.7
Net income (loss) 192.0 73.3 (88.0) (117.2) (104.0)
Basic net income (loss) per ordinary share 0.45 0.17 (0.20) (0.27) (0.24)
Diluted net income (loss) per ordinary share 2 0.44 0.17 (0.20) (0.27) (0.24)
Number of ordinary shares used in computing per share amounts (in thousands):
Basic 431,221 431,672 431,989 432,112 432,454
Diluted 2 434,585 434,491 431,989 432,112 432,454

Three months ended,

ASML - Quarterly Summary Ratios and other data 1

Three months ended,

Jun 29,
2008
Sep 28,
2008
Dec 31,
2008
Mar 29,
2009
Jun 28,
2009
Gross profit as a % of net sales 40.0 38.1 7.9 6.7 12.5
Income (loss) from operations as a % of net sales 17.9 12.0 (27.4) (80.0) (45.0)
Net income (loss) as a % of net sales 22.7 10.5 (17.8) (63.8) (37.6)
Shareholders' equity as a % of total assets 49.7 50.3 50.5 48.0 47.7
Income taxes as a % of income before income taxes 22.1 (18.9) (32.4) (20.8) (16.6)
Sales of systems (in units) 39 37 25 11 10
ASP of system sales (EUR million) 18.6 16.0 15.2 9.2 18.3
Value of backlog systems (EUR million) 1,106 1,028 755 853 1,064
Backlog systems (in units) 59 53 41 38 43
ASP of backlog systems (EUR million) 18.8 19.4 18.4 22.4 24.7
Value of booked systems (EUR million) 632 498 127 207 394
Net bookings (in units) 33 31 13 8 15
ASP of booked systems (EUR million) 19.2 16.1 9.8 25.8 26.3
Number of payroll employees in FTEs 6,821 6,907 6,930 6,715 6,597
Number of temporary employees in FTEs 1,649 1,610 1,329 959 868
Jun 29, Sep 28, Dec 31, Mar 29, Jun 28,
2008 2008 2008 2009 2009
(in millions EUR)
ASSETS
Cash and cash equivalents 1,360.9 1,313.0 1,109.2 1,151.0 1,092.7
Accounts receivable, net 516.7 536.1 463.3 291.6 213.5
Finance receivables, net 0.2 7.4 6.2 6.2 0.1
Current tax assets - - 87.6 - -
Inventories, net 1,130.2 1,134.0 999.1 936.8 926.1
Deferred tax assets 69.8 82.8 71.8 74.9 70.5
Other assets 262.2 261.4 236.1 240.6 220.2
Total current assets 3,340.0 3,334.7 2,973.3 2,701.1 2,523.1
Finance receivables, net - 30.7 31.0 29.2 20.6
Deferred tax assets 157.7 139.4 148.1 173.2 198.9
Other assets 39.3 50.6 88.2 89.5 53.8
Goodwill 119.8 129.2 131.5 139.7 134.5
Other intangible assets, net 30.1 28.8 26.7 25.6 22.3
Property, plant and equipment, net 458.1 503.1 540.6 586.6 591.9
Total non-current assets 805.0 881.8 966.1 1,043.8 1,022.0
Total assets 4,145.0 4,216.5 3,939.4 3,744.9 3,545.1
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 1,247.3 1,273.0 1,008.3 1,017.5 940.9
Long-term debt 591.6 596.7 647.1 661.4 651.9
Deferred and other tax liabilities 227.0 215.2 209.7 204.9 200.6
Provisions - - 15.5 16.9 14.8
Accrued liabilities and other liabilities 18.5 8.8 70.0 48.2 45.6
Total non-current liabilities 837.1 820.7 942.3 931.4 912.9
Total liabilities 2,084.4 2,093.7 1,950.6 1,948.9 1,853.8
Shareholders' equity 2,060.6 2,122.8 1,988.8 1,796.0 1,691.3
Total liabilities and shareholders' equity 4,145.0 4,216.5 3,939.4 3,744.9 3,545.1

ASML - Summary U.S. GAAP Consolidated Balance Sheets 1

ASML - Summary U.S. GAAP Consolidated Statements of Cash Flows 1

Three months ended,

Jun 29, Sep 28, Dec 31, Mar 29, Jun 28,
2008 2008 2008 2009 2009
(in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) 192.0 73.3 (88.0) (117.2) (104.0)
Depreciation and amortization 26.5 28.6 35.1 37.9 31.6
Impairment 0.1 0.6 22.9 2.6 4.4
Loss on disposals of property, plant and equipment 1.3 1.4 0.4 2.6 8.7
Share-based payments 3.1 3.7 3.2 3.5 2.6
Allowance for doubtful debts (0.6) (0.2) 0.5 - 1.2
Allowance for obsolete inventory 11.8 21.3 85.8 22.1 43.9
Deferred income taxes (54.5) 2.4 (2.7) (27.0) (31.2)
Change in assets and liabilities (49.7) (110.2) (194.6) 157.7 113.8
Net cash provided by (used in) operating activities 130.0 20.9 (137.4) 82.2 71.0
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (65.5) (68.3) (71.1) (43.9) (43.3)
Proceeds from sale of property, plant and equipment - - - 1.2 -
Net cash used in investing activities (65.5) (68.3) (71.1) (42.7) (43.3)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (107.4) (0.4) - - (86.5)
Net proceeds from issuance of shares and stock options 0.5 1.4 6.5 0.1 0.4
Excess tax benefits (deficiencies) from stock options 6.0 (1.9) (1.9) (0.2) 0.5
Net proceeds from other long-term debt - - - - 0.1
Redemption and/or repayment of debt - (1.3) (1.1) - -
Net cash provided by (used in) financing activities (100.9) (2.2) 3.5 (0.1) (85.5)
Net cash flows (36.4) (49.6) (205.0) 39.4 (57.8)
Effect of changes in exchange rates on cash 0.2 1.7 1.2 2.4 (0.5)
Net increase (decrease) in cash & cash equivalents (36.2) (47.9) (203.8) 41.8 (58.3)

ASML - Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America ("U.S. GAAP"). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros ('EUR').

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majorityowned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML's consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller's price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a "Factory Acceptance Test" in ASML's clean room facilities, effectively replicating the operating conditions that will be present on the customer's site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system's performance is re-tested upon installation at the customer's site, ASML has never failed to successfully complete installation of a system at a customer's premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company's policy to hedge material transaction exposures, such as sales transactions, forecasted purchase transactions and accounts receivable/accounts payable. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company's policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of June 28, 2009 EUR 36.9 million loss of other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 1.2 million gain representing the total anticipated gain to be released to cost of sales when the forecasted revenue and purchase transactions occur.

Net income Three months ended, Six months ended, Jun 29, 2008 Jun 28, 2009 Jun 29, 2008 Jun 28, 2009 (in thousands EUR) Net income (loss) under U.S. GAAP 191,977 (103,953) 337,100 (221,144) Share-based payments (see Note 1) 245 1,396 (518) 897 Capitalization of development costs (see Note 2) 18,649 21,760 40,330 33,275 Income taxes (see Note 3) (380) (458) 39 (2,058) Net income (loss) under IFRS 210,491 (81,255) 376,951 (189,030) Shareholders' equity Jun 29, Sep 28, Dec 31, Mar 29, Jun 28, 2008 2008 2008 2009 2009 (in thousands EUR) Shareholders' equity under U.S. GAAP 2,060,575 2,122,848 1,988,769 1,795,951 1,691,240 Share-based payments (see Note 1) (3,266) (7,904) (6,537) (7,088) (4,918) Capitalization of development costs (see Note 2) 176,818 193,780 201,717 215,452 235,945 Income taxes (see Note 3) 8,478 5,969 4,794 3,361 2,797 Shareholders' equity under IFRS 2,242,605 2,314,693 2,188,743 2,007,676 1,925,064

ASML – Reconciliation U.S. GAAP – IFRS 1

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, "Share-based Payments" beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRSs, a deferred tax asset is computed on the basis of the tax deduction for the share-based payments every period under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company's share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies SFAS No. 123(R) "Share-Based Payment" which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. FAS 123(R)'s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements. Therefore, changes in the Company's share price do not affect the deferred tax asset recorded in the Company's financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, "Intangible Assets". In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies SFAS No. 2, "Accounting for Research and Development Costs". In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Income taxes

Under IFRS, ASML applies IAS 12, "Income Taxes" beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser's tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller's tax jurisdiction.

Statutory Interim Report

On July 24, 2009 ASML will publish its Statutory Interim Report for the six months period ended June 28, 2009. This report is in accordance with the requirements of the EU Transparency Directive and will include an Interim Management Board Report, a Managing Directors' Statement and Consolidated Condensed Interim Financial Statements in accordance with IAS 34, "Interim Financial Reporting". The EU Transparency Directive is applicable for all listed companies as of January 1, 2009. The Statutory Interim Report for the six months period ended June 28, 2009 will be available online at www.asml.com.

"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1 All quarterly information in this press release is unaudited. 2

The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.